Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
FEMALE
NCT06575868

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

Led by Tufts Medical Center · Updated on 2025-04-29

40

Participants Needed

1

Research Sites

121 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Myoinositol is an insulin-like compound that is present in both plant and animal cells. Humans synthesize it naturally, but it is also obtained in our diet. It works through an intracellular signaling pathway to increase insulin sensitivity. Myoinositol has been used as an over-the-counter (OTC) supplement in the management of polycystic ovarian syndrome due to this effect. Myoinositol has also been shown to improve glycemic profiles in pregnant euglycemic women and well as improve insulin sensitivity in pregnant patients with gestational diabetes mellitus (GDM). This is a double blind RCT offering myo-inositol or placebo to those who are eligible and enrolled.

CONDITIONS

Official Title

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Singleton gestations
  • Women aged > 18 years and < 45 years
  • Recruited before 16 weeks gestation
  • Obese (pre-pregnancy BMI 8 30)
  • Receiving prenatal care at Tufts Medical Center
  • Planning to give birth at Tufts Medical Center
  • Can tolerate glucose tolerance test
  • Willing and able to wear CGM
  • Willing and able to sign informed consent
Not Eligible

You will not qualify if you...

  • Multiple gestation
  • Preexisting diabetes
  • Taking medications that impact body weight or metabolism (eg metformin)
  • Inability to tolerate glucose tolerance test
  • Adults unable to consent (cognitively impaired adults)
  • Wards of the state
  • Non-viable neonates
  • Neonates of uncertain viability

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tufts Medical Center

Boston, Massachusetts, United States, 02111

Actively Recruiting

Loading map...

Research Team

Z

Zeinab Kassem, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Myo-inositol During Pregnancy to Prevent Gestational Diabetes | DecenTrialz